| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025397 |
| Receipt No. | R000029236 |
| Official scientific title of the study | Effect of Salacia oblonga extract on blood pressure in high-normal blood pressure or grade I hypertension subjects: a dose-comparison trial |
| Date of disclosure of the study information | 2016/12/27 |
| Last modified on | 2017/08/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Effect of Salacia oblonga extract on blood pressure in high-normal blood pressure or grade I hypertension subjects: a dose-comparison trial | |
| Title of the study (Brief title) | Effect of Salacia oblonga extract on blood pressure in high-normal blood pressure or grade I hypertension subjects: a dose-comparison trial | |
| Region |
|
|
| Condition | |||
| Condition | Healthy volunteers
Hypertension |
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate blood pressure-lowering effect of Salacia oblonga extract comparing two doses in high-normal blood pressure or grade I hypertension subjects. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 3-week change in home blood pressure |
| Key secondary outcomes | 3-week change in ankle-brachial index (ABI) and office blood pressure |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Dose comparison |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects receive 6 tablets/day (2 tablets/time) containing a total of 180 mg of Salacia oblonga extract for 3 weeks. | |
| Interventions/Control_2 | Subjects receive 6 tablets/day (2 tablets/time) containing a total of 540 mg of Salacia oblonga extract for 3 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Diagnosed as high-normal blood pressure or grade I hypertension through health checks twice or more in three years
2) With habit of eating 3 meals a day |
|||
| Key exclusion criteria | 1) Taking antihypertensive
2) Taking medicines for chronic disease other than antihypertensive 3) Taking functional food that may affect the trial 4) Participation in any clinical trial within 90 days of the commencement of the trial 5) In pregnancy or nursing a child 6) Judged as ineligible by clinical investigators |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Fumiko Higashikawa |
| Organization | Hiroshima University, Institute of Biomedical & Health Sciences |
| Division name | Project Research Center for Clinical Trial and Preventive Medicine |
| Address | Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN |
| TEL | 082-257-1533 |
| fumiko@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Fumiko Higashikawa |
| Organization | Hiroshima University, Institute of Biomedical & Health Sciences |
| Division name | Project Research Center for Clinical Trial and Preventive Medicine |
| Address | Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN |
| TEL | 082-257-1533 |
| Homepage URL | |
| fumiko@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TAKAMA Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 広島大学病院(広島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029236 |